References
- 1. D. D. Bikle, Vitamin D metabolism, mechanism of action, and clinical applications, Chem. Biol. 21 (2014) 319–329; DOI: 10.1016/j.chembiol.2013.12.016.
- 2. C. Carlberg, S. Seuter and S. Heikkinen, The first genome-wide view of vitamin D receptor locations and their mechanistic implications, Anticancer Res.32 (2012) 271–282.
- 3. E. De Luca d’Alessandro, S. Bonacci and G. Giraldi, Aging populations: the health and quality of life of the elderly, Clin. Ter.162 (2011) e13-e18.
- 4. A. Prentice, Vitamin D deficiency: a global perspective, Nutr. Rev.66 (10 Suppl. 2) (2008) S153-S164; DOI: 10.1111/j.1753-4887.2008.00100.x.
- 5. W. B. Grant, Epidemiology of disease risks in relation to vitamin D insufficiency, Prog. Biophys. Mol. Biol.92 (2006) 65–79; DOI: 10.1016/j.pbiomolbio.2006.02.013.
- 6. R. Przybylski, S. McCune, B. Hollis and R. U. Simpson, Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat, Nutr. Metab. Cardiovasc. Dis.20 (2010) 641–646; DOI: 10.1016/j.numecd.2009.07.009.
- 7. G. Giraldi, E. De Luca d’Alessandro, A. Mannocci, V. Vecchione and L. Martinoli, A pilot study of the effect of pantothenic acid in the treatment of post-operative ileus: results from an orthopedic surgical department, Clin. Ter.163 (2012) e121-e126.
- 8. M. R. Haussler, P. W. Jurutka, M. Mizwicki and A. W. Norman, Vitamin D receptor (VDR)-mediated actions of 1α,25(H)2 vitamin D3: genomic and non-genomic mechanisms, Best Pract. Res. Clin. Endocrinol. Metab. Endocrinol. Metab. 25 (2011) 543–559.
- 9. Y. Wang, J. Zhu and H. F. DeLuca, Where is the vitamin D receptor? Arch. Biochem. Biophys. 523 (2012) 123–133; DOI: 10.1016/j.abb.2012.04.001.
- 10. P. Marini, L. Romanelli, D. Valeri, P. Tucci, P. Valeri and M Palmery, Acute withdrawal induced by adenosine A-receptor activation in isolated guinea-pig ileum: role of opioid receptors and effect of cholecystokinin, J. Pharm. Pharmacol.62 (2010) 622–632.
- 11. J. W. Pike and M. B. Meyer, The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3), Endocrinol. Metab. Clin. North Am.39 (2012) 255–269; DOI: 10.1016/j.ecl.2010.02.007.
- 12. S. Christakos, Mechanism of action of 1,25-dihydroxyvitamin D3 on intestinal calcium absorption, Rev. Endocr. Metab. Disord. 13 (2012) 39–44; DOI: 10.1007/s11154-011-9197-x.
- 13. R. M. Eglen, S. S. Hedge and N. Watson, Muscarinic receptor subtypes and smooth muscle function, Pharmacol. Rev. 48 (1996) 531–565.